Kate Prine is a seasoned Senior Talent Acquisition Business Partner at Pfizer, where she leverages over a decade of specialized recruiting experience in the pharmaceutical industry. Her expertise spans critical areas such as Research & Development, clinical operations, commercial functions, and corporate roles, positioning her...
Kate Prine is a seasoned Senior Talent Acquisition Business Partner at Pfizer, where she leverages over a decade of specialized recruiting experience in the pharmaceutical industry. Her expertise spans critical areas such as Research & Development, clinical operations, commercial functions, and corporate roles, positioning her as a vital asset in the ever-evolving landscape of drug development and commercialization. With Pfizer's recent acquisition of Seagen in December 2023, Kate is at the forefront of integrating talent acquisition strategies that align with the company's ambitious goals in oncology and innovative therapies.
In her current role, Kate is responsible for spearheading key projects that enhance Pfizer's recruitment processes, focusing on attracting top-tier talent to drive clinical research and quality assurance initiatives. Her proficiency in executive search and direct hire processes ensures that Pfizer secures the best candidates for leadership positions, particularly in clinical data management and regulatory affairs. Kate's strong communication skills and her ability to engage as a public speaker allow her to effectively advocate for Pfizer's employer brand, particularly in outreach efforts aimed at veteran hiring—a cause she is deeply passionate about.
With an MBA concentrating in Human Resources and a Bachelor of Science in Psychology, Kate combines her academic background with practical insights to foster a diverse and inclusive workplace. Her commitment to enhancing the candidate experience and her strategic approach to talent acquisition make her a key player in Pfizer's mission to deliver breakthroughs that change patients' lives. As the pharmaceutical industry continues to evolve, Kate's role will be instrumental in navigating the complexities of talent management and ensuring that Pfizer remains a leader in the field.
